Specifically, the automated procedure was not able to map some well-known cancer genes, including cyclin-dependent kinase inhibitor 2A (CDKN2A), F-box and WD repeat domain containing 7 (FBXW7), and E2F transcription factor 3 (E2F3), to a hallmark. Here, CDKN2A is linked to cancer.